Company
Galderma
Galderma has 34 drugs tracked on RxWires: 17 post-market, 3 approved, 8 in Phase 3, 3 in Phase 2, 3 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Adapalene 0.3% / benzoyl peroxide 2.5% emulsion gel | Post-Market | Acne Vulgaris |
| Clobetasol Propionate 0.05% Spray | Post-Market | Psoriasis |
| tetracaine 7% / lidocaine 7% cream (Pliaglis® Cream) | Post-Market | Nasolabial Folds |
| Azzalure or Dysport | Post-Market | Aesthetics |
| "Cetaphil Healing Ointment" | Post-Market | Diaper Rash |
| Restylane-L® | Post-Market | Cosmetic Techniques |
| Adapalene | Post-Market | Acne Vulgaris |
| Epiduo Gel | Post-Market | Acne Vulgaris |
| Facial Cleanser and Moisturizer SPF 30 | Post-Market | Acne Prone Skin |
| calcitriol ointment | Post-Market | Plaque Psoriasis |
| Clobex Spray | Post-Market | Plaque Psoriasis |
| Ivermectin 1% cream | Post-Market | Rosacea |
| Azzalure | Post-Market | Facial Aesthetic Treatment |
| Cetaphil | Post-Market | Plaque Psoriasis |
| Trifarotene Cream | Post-Market | Acne Vulgaris |
| adapalene/benzoyl peroxide | Post-Market | Acne |
| clobetasol propionate spray | Post-Market | Plaque Psoriasis |
| MIRVASO | Approved | |
| CLOBETASOL PROPIONATE | Approved | |
| METVIXIA | Approved | |
| Botulinum Toxin Type A | Phase 3 | Canthal Lines |
| Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel | Phase 3 | Acne |
| botulinum toxin neuromodulator | Phase 3 | Glabellar Lines |
| Nemolizumab | Phase 3 | Moderate-to-Severe Atopic Dermatitis |
| Metvix® cream | Phase 3 | Superficial Basal Cell Carcinoma |
| QM1114-DP | Phase 3 | Glabellar Frown Lines |
| CD5789 (trifarotene) 50µg/g Cream | Phase 3 | Acne Vulgaris |
| GK530G | Phase 3 | Acne Vulgaris |
| CD 2027 | Phase 2 | Plaque-type Psoriasis |
| AbobotulinumtoxinA dose level 1 or 2 | Phase 2 | Glabellar Frown Lines |
| AbobotulinumtoxinA dose 1 | Phase 2 | Platysmal Bands |
| adapalene cream 0.1% | Phase 1 | Skin Manifestations |
| occlusive bandage | Phase 1 | Healthy |
| Restylane® Lyft | Phase 1 | Hand Rejuvination |
Latest
Follow Galderma on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.